4
Total investments
0
Early stage
3
Mid stage
1
Late stage
5y
Years active
Portfolio
4 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Observer
Jan 2025
HydRegen’s industrial biotechnology platforms deliver sustainable, safe and cost-efficient chemical processes.
Partnerships with major chemicals companies have validated these technologies as ‘slot in’ replacements to precious metal catalysts, in existing chemical manufacturing infrastructure, providing a route to fast-tracking adoption of more sustainable bio-based manufacturing across the chemical sectors (current joint development projects in specialty, personal care, materials, and generics).
By combining the benefits of milder biological conditions within intensified chemical infrastructure, we unlock at least 3xCO2e and 40% cost savings to our customers.
We are now looking to raise £5-8m, focusing on delivering our first product (Bio2Amine) to a first 38 processes, with an end-market of £80bn and opportunity to HydRegen of £105m reoccurring revenue, before ramping our follow on products into additional markets.
For Investors: https://hydregenoxford.com/investors
Board Observer
Jan 2023
Our plug sockets, powered by machine learning, identify your devices and continually measure their usage, automatically turning them on and off to eliminate small power waste.
They actively minimise your carbon emissions, helping you to achieve your net zero goals, whilst reducing your electricity costs by at least 20%.
With a return on investment within a maximum of 2 years, it’s never been easier to save the planet and your pocket.
Board Observer
Feb 2022
Founded in 2016 by Will Hitchcock, we have worked on over 4000 solar assets and are supporting customers across six continents. We work with many of the world’s leading solar energy companies to deliver solar plant data and analytics through our interactive platform, SolarGain.
Our suite of intelligent software and inspection solutions span the entire solar plant lifecycle enabling precision design, forensic construction oversight, rigorous commissioning and efficient high-quality solar plant management.
Experience · 8 entries
All (8)
Investments (4)
Board (4)
2025
Board Observer
Jan 2025
HydRegen’s industrial biotechnology platforms deliver sustainable, safe and cost-efficient chemical processes.
Partnerships with major chemicals companies have validated these technologies as ‘slot in’ replacements to precious metal catalysts, in existing chemical manufacturing infrastructure, providing a route to fast-tracking adoption of more sustainable bio-based manufacturing across the chemical sectors (current joint development projects in specialty, personal care, materials, and generics).
By combining the benefits of milder biological conditions within intensified chemical infrastructure, we unlock at least 3xCO2e and 40% cost savings to our customers.
We are now looking to raise £5-8m, focusing on delivering our first product (Bio2Amine) to a first 38 processes, with an end-market of £80bn and opportunity to HydRegen of £105m reoccurring revenue, before ramping our follow on products into additional markets.
For Investors: https://hydregenoxford.com/investors
2024
Private Equity Associate
Jan 2024
Pictet is an investment-led service company, offering wealth management, asset management and related services.
We are an independent investment partnership known for our long-term mindset, responsible approach to business and entrepreneurial spirit. These principles have defined us since 1805. For our clients, colleagues, and wider society, we always aim to do the right thing and honour our commitment to enduring quality.
With more than CHF 686 billion in assets under management or custody as of December 31st 2023, Pictet is today one of the leading Europe-based independent wealth and asset managers.
The Group is headquartered in Geneva, where its activities began, and employs more than 5000 employees. With 30 offices, it is also present in Amsterdam, Basel, Barcelona, Brussels, Dubai, Frankfurt, Hong Kong, Lausanne, London, Luxembourg, Madrid, Milan, Monaco, Montreal, Munich, Nassau, Osaka, Paris, Rome, Shanghai, Singapore, Stuttgart, Taipei, Tel-Aviv, Tokyo, Turin, Verona, Shanghai, New York and Zurich.
2023
Board Observer
Jan 2023
Our plug sockets, powered by machine learning, identify your devices and continually measure their usage, automatically turning them on and off to eliminate small power waste.
They actively minimise your carbon emissions, helping you to achieve your net zero goals, whilst reducing your electricity costs by at least 20%.
With a return on investment within a maximum of 2 years, it’s never been easier to save the planet and your pocket.
2022
Board Observer
Feb 2022
Founded in 2016 by Will Hitchcock, we have worked on over 4000 solar assets and are supporting customers across six continents. We work with many of the world’s leading solar energy companies to deliver solar plant data and analytics through our interactive platform, SolarGain.
Our suite of intelligent software and inspection solutions span the entire solar plant lifecycle enabling precision design, forensic construction oversight, rigorous commissioning and efficient high-quality solar plant management.
2021
Investment Associate
Oct 2021
CGF invest in tech innovations that reduce greenhouse gas emissions or improve resource efficiency across power, transport, industry, buildings, waste and water.
We look for UK early stage companies with commercially viable solutions that are generating early revenues and also consider pre-revenue businesses with a minimum viable product.
Show all 8 entries ↓
Investment activity
2021–2025 · 4 investments
Recent (last 2 years)Earlier
